Default company panoramic image

Lakewood Amedex Inc

Lakewood Amedex is developing a revolutionary portfolio of products to meet the infectious disease challenges of the 21st century.

  • Stage Concept Only
  • Industry Not Set
  • Location Lakewood Ranch, FL, USA
  • Currency USD
  • Website

Company Summary

Lakewood-Amedex, a private development stage biopharmaceutical company, is developing a diverse portfolio of broad spectrum anti-bacterials, anti-virals, and targeted therapeutics. NuBiotics are a synthetic broad spectrum first in class group of anti-bacterial compounds that represent a first line defence against the increasing number of antibiotic resistant bacteria.


  • Default avatar
    Steve Parkinson
    President and CEO

    Mr. Parkinson has over 28 years experience in the biotechnology and biopharmaceutical industry. As co-founder and CEO of TranXenoGen, Mr. Parkinson oversaw its IPO and admission to AIM in July of 2000, increasing its market value from $90M to $240M within one year. As President and CEO of CereMedix, a drug discovery and development company, he advanced their first product to clinical trials.

  • Default avatar
    Paul DiTullio
    VP Product Development

    Mr. DiTullio has 20 years in the biotechnology/biopharmaceutical industry that has provided a broad range of scientific, finance, and business experience associated with early stage company development. Previously, Mr. DiTullio was a co-founder and VP of Product Development for TranXenoGen Inc and was responsible for coordinating all research and product development activities.